Spots Global Cancer Trial Database for Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Official Title: A Phase IV, Long-term, Open-label, Multicenter Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
Study ID: NCT00504959
Interventions
Study Description
Brief Summary: This extension study will investigate the long-term safety and tolerability of multiple intravitreal injections of ranibizumab administered to patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration who have been previously treated in either of the two ongoing ranibizumab studies CRFB002A2302 (EXCITE) or CRFB002A2303 (SUSTAIN
Detailed Description:
Eligibility
Minimum Age: 50 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Novartis Investigational Site, Melbourne, , Australia
Novartis Investigative Site, Laeken, , Belgium
Novartis Investigative Site, Leuven, , Belgium
Novartis Investigative Site, Liege, , Belgium
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Bonn, , Germany
Novartis Investigative Site, Bremen, , Germany
Novartis Investigative Site, Chemnitz, , Germany
Novartis Investigative Site, Duesseldorf, , Germany
Novartis Investigative Site, Kiel, , Germany
Novartis Investigative Site, Koeln, , Germany
Novartis Investigative Site, Leipzig, , Germany
Novartis Investigative Site, Marburg, , Germany
Novartis Investigative Site, Muenchen, , Germany
Novartis Investigative Site, Siegburg, , Germany
Novartis Investigative Site, Tubingen, , Germany
Novartis Investigative Site, Wuerzburg, , Germany
Novartis Investigative Site, Budapest, , Hungary
Novartis Investigative Site, Debrecen, , Hungary
Novartis Investigative Site, Petach-Tikva, , Israel
Novartis Investigative Site, Tel - Hashomer, , Israel
Novartis Investigative Site, Tel-Aviv, , Israel
Novartis Investigative Site, Amsterdam, , Netherlands
Novartis Investigative Site, Nijmegen, , Netherlands
Novartis Investigative Site, Coimbra, , Portugal
Novartis Investigative Site, Porto, , Portugal
Novartis Investigative Site, Alicante, , Spain
Novartis Investigative Site, Barcelona, , Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Santiago de Compostela, , Spain
Novartis Investigative Site, Valencia, , Spain
Novartis Investigative SIte, Ankara, , Turkey
Novartis Investigative Site, Bristol, , United Kingdom
Novartis Investigative Site, Southampton, , United Kingdom
Novartis Investigative Site, West Midlands, , United Kingdom
Novartis Investigative Site, Wolverhampton, , United Kingdom
Contact Details
Name: Novartis
Affiliation: Board of Hacettepe University , Ankara, turkey
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
